Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/SCYNEXIS, Inc.
Company profile

SCYNEXIS, Inc.

NASDAQ: SCYX · Healthcare · Medical - Pharmaceuticals
PublicHQ Jersey City, NJ · HudsonCIK 0001178253Reports USD
#536 of 1,394 Healthcare companies by revenuetop-decile growth
EA Score
61C
FH 56DQ 70GM 62SS 48
v0.1 · 65/100 weight · provisional
↑ revenue growth (YoY), balance-sheet leverage · ↓ growth stability, Piotroski F
Methodology →
Revenue TTM
$20.3M
Rev growth YoY (TTM)
+673.5%
Net income (FY)
-$8.6M
Employees
18
Market cap
$27.9M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$20.6M$20.6M2025
Net income-$8.6M-$8.6M2025
Operating income-$16.1M-$16.1M2025
Total assets$59.0M$59.0M2025
Liabilities$9.7M$9.7M2025
Equity$49.4M$49.4M2025

Revenue trend

FY2018 – FY2025 · USD
$257.0k
FY18
$121.0k
FY19
$0
FY20
$13.2M
FY21
$5.1M
FY22
$140.1M
FY23
$3.7M
FY24
$20.6M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
License and Service93%
Product7%
By geography

Not disclosed.

The read

SCYNEXIS, Inc. booked $20.6M in FY2025 revenue, growing 450% year over year — faster than 94% of Healthcare companies we track, at a -41.8% net margin.

Peers · Healthcare
Telescope Innovations Corp.——Harvard Bioscience, Inc.58CRein Therapeutics Inc.36DCryo-Cell International, Inc.63C
Neighbors
Hudson →
Verisk Analytics, Inc.$3.1B75B+Quest Diagnostics Incorporated$11.0B88AOrganon & Co.$6.2B66BProvident Financial Services, Inc.$73.1M60CJohn Wiley & Sons, Inc.$1.7B83B+AvePoint, Inc.$419.5M66B
Key facts
CEODavid Angulo
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersJersey City, NJ
ExchangeNASDAQ: SCYX
Employees18
IPO date2014-05-02
Latest filings
8-K2026-06-268-K2026-05-298-K2026-05-2210-Q2026-05-11DEF 14A2026-04-30DEF 14A2026-04-278-K2026-04-208-K2026-03-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies